NewslettersCell Therapy News FDA Warns of Secondary Cancer Risk Tied to CAR-T Therapies That Treat Cancer By lbeveridge - January 29, 2024 0 The US FDA has issued a new warning about the possible risk of secondary cancers in cancer patients who have been treated with a form of immunotherapy called chimeric antigen receptor T-cell, or CAR-T cell, therapy. [CNN] Press Release